# Mile High Labs Files Type II Drug Master File with FDA for CBD Isolate

- Source: PR Newswire M&A
- Published: 2026-11-19T19:34:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/mile-high-labs-files-type-ii-drug-master-file-with-fda-for-cbd-isolate-302946042.html
- Canonical: https://groundlevelnews.com/story/mile-high-labs-files-type-ii-drug-master-file-with-fda-for-cbd-isolate-4a2f77/

Mile High Labs continues to build its pharmaceutical-channel capabilities with a Type II DMF for CBD Isolate LOVELAND, Colo., Nov. 19, 2026 /PRNewswire/ -- Mile High Labs, a global leader in hemp-derived cannabinoid ingredients, today announced that it has filed a Type II Drug Master File...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
